About
Exosomes
Areas of Focus
Categories
Non-PharmaceuticalSoutheastern U.S.
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
1
By Phase
PHASE1/PHASE2: 1PHASE2: 1
By Status
WITHDRAWN: 1TERMINATED: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT02536495Lead Sponsor
Selinexor and Docetaxel in Treating Patients With Recurrent or Metastatic Squamous Cell Lung Cancer
PHASE1/PHASE2Withdrawn
Started: Sep 30, 2015
NCT02351505Lead Sponsor
Selinexor in Treating Patients With Relapsed Small Cell Lung Cancer
PHASE2Terminated
1 participants
Started: May 31, 2015 · Completed: Mar 31, 2016
Funding History (1)
D
Aug 5, 2022
Locations (1)
Headquarters
Alachua, FL, United States
Map
Loading map...